Cardiac magnetic resonance in acute myocarditis: A new non-invasive diagnostic gold standard?;IRM cardiaque: Imagerie de référence dans le diagnostic de la myocardite aiguë?

Revue Medicale Suisse

Volumn 8, Issue 343, 2012, Pages 1177-1183

  Monney, P ^a   Locca, D ^a   Muzzarelli, S ^a   Hullin, R ^a   Jeanrenaud, X ^a   Schwitter, J ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; EPICARDIUM MAPPING; FOLLOW UP; HEART EDEMA; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HUMAN; MYOCARDITIS; PATIENT MONITORING; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ACUTE DISEASE; BIOPSY; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; GOLD; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS; PROGNOSIS; REFERENCE STANDARDS;

EID: 84864012479     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis : A histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
2. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of imunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-75.
3. Hauck AJ, Kearney DL, Edwards WD. Evaluation of post-mortem endomyocardial biopsy specimen from 38 patients with lymphocytic myocarditis : Implications for role of sampling error. Mayo Clin Proc 1989;64:1235-45. (Pubitemid 20005759)
4. Baughman KL. Diagnosis of myocarditis : Death of Dallas criteria. Circulation 2006;113:593-5.
5. *Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur Heart J 2008;29:2073-82.
6. Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy : A seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 1992;1:43-7.
7. *Cooper LT, Baughman KL, Feldman Al, et al. The role of myocardial biopsy in the management of cardiovascular disease. A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007;28:3076-93. (Pubitemid 350262258)
8. Magnani JW, Dec GW. Myocarditis : Current trends in diagnosis and treatment. Circulation 2006;113:876-90.
9. Hufnagel G, Pankuweit S, Richter A, et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) : First epidemiological results. Herz 2000;25:279-85. (Pubitemid 30422178)
10. Morgera T, Di Lenarda A, Dreas L, et al. Electrocardiography of myocarditis revisited : Clinical and prognostic significance of electrocardiographic changes. Am Heart J 1992;124:455-67.
11. Magnani JW, Danik HJ, Dec GW, et al. Survival in biopsy-proven myocarditis : A long-term restrospective analysis of histopathologic, clinical, and hemodynamic predictors. Am Heart J 2006;151:463-70. (Pubitemid 43144751)
12. Nakashima H, Katayama T, Ishizaki M, et al. Q wave and non Q wave myocarditis with special reference to clinical significance. Jpn Heart J 1998;39:763-74. (Pubitemid 29050529)
13. Smith SC, Ladenson JH, Mason JW, et al. Elevation of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997;95:163-8. (Pubitemid 27029958)
14. Felker GM, Boehmer JP, Hruban RH, et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 2000;36:227-32. (Pubitemid 30466138)
15. Mendes LA, Dec HW, Picard MH, et al. Right ventricular dysfunction : An independent predictor of adverse outcome in patients with myocarditis. Am Heart J 1994;128:301-7. (Pubitemid 24259154)
16. **Cooper LT. Myocarditis. N Engl J Med 2009;360:1526-38.
17. Kuhl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with «idiopathic» left ventricular dysfunction. Circulation 2005;111:887-93. (Pubitemid 40279890)
18. Mason JW. Myocarditis and dilated cardiomyopathy : An inflammatory link. Cardiovasc Res 2003;60:5-10. (Pubitemid 38373471)
19. D'ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy : A review. Heart 2001;85:499-504.
20. *Grün S, Schumm J, Greulich S, et al. Long term follow-up of biopsy-proven viral myocarditis. Predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012, in press.
21. Dickstein K, Cohen-Solal A, Filippatos, G et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.
22. McCarthy RE, Boehmer JP, Hruban RH, et al. Long term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5. (Pubitemid 30131421)
23. Cabinian AE, Kiel RJ, Smith F, et al. Modification of exercise-aggravated coxsackievirus B3 murine myocarditis by T lymphocyte suppression in an inbred model. J Lab Clin Med 1990;115:454-62. (Pubitemid 20143393)
24. Khatib R, Reyes MO, Smith F, et al. Enhancement of Coxsackie-virus B4 virulence by indomethacin. J Lab Clin Med 1990;116:116-20.
25. Costanzo-Nordin MR, Reap EA, O'Connell JB, et al. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. J Am Coll Cardiol 1985;6:1078-82. (Pubitemid 16219205)
26. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy : The TIMIC study. Eur Heart J 2009;30:1995-2002.
27. *Schulz-Menger J, Mahrholdt H, Pennell D, et al. Cardiomyopathies. In : CMR-Update p. 134. Editor and Publisher : J. Schwitter, 1. edition. Zurich, Switzerland. www.herz-mri.ch
28. Kim RJ, Wu E, Rafael A, et al. The use of contrast enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
29. Mahrholdt H, Wagner A, Judd RM, et al. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002;23:602-19. (Pubitemid 35204245)
30. Rieker O, Mohrs O, Oberholzer K, et al. Cardiac MRI in suspected myocarditis. ROFO : Fortschritte auf dem Gebiete der Roentgenstrahlen und der Nuklearmedizin 2002;174:1530-6. (Pubitemid 36055034)
31. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis. A comparison to histology and molecular pathology. Circulation 2004;109:1250-8. (Pubitemid 38379570)
32. Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis. Comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22. (Pubitemid 40779862)
33. Hunold P, Schlosser T, Vogt FM, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI : Distinction between infarction scar and non-infarction-related disease. AJR 2005;184:1420-6. (Pubitemid 43821809)
34. Laissy JP, Hyafil F, Feldman LJ, et al. Differentiating acute myocardial infarction from myocarditis : Diagnostic value of early - and delayed-perfusion cardiac MR imaging. Radiology 2005;237:75-82. (Pubitemid 41346148)
35. Ingkanisorn WP, Paterson DI, Calvo KR, et al. Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2 : Similarities to community-acquired myocarditis. J Cardiovasc Magn Reson 2006;8:353-60.
36. DeCobelli F, Pieroni M, Esposito A, et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 2006;47:1649-54.
37. Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114:1581-90. (Pubitemid 44547428)
38. Roditi GH, Hartnell GG, Cohen MC, et al. MRI changes in myocarditis - evaluation with spin echo, cine MR angiography and contrast enhanced spin echo imaging. Clin Radiol 2000;114:1581-90.
39. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocaditis at cardiac MR : Diagnostic accuracy and association with immunologically detected inflammation and viral persistence. Radiology 2008;246:401-9.
40. Monney P, Sekhri N, Burchell T, et al. Acute myocarditis presenting as acute coronary syndrome : Role of early cardiac magnetic resonance in its diagnosis. Heart 2011;97:1312-8.
41. Laissy JP, Messin B, Varenne O, et al. MRI of acute myocarditis : A comprehensive approach based on various imaging sequences. Chest 2002;122:1638-48. (Pubitemid 35366076)
42. Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement end elevated inflammatory markers can predict the reversibility of constrictive pericarditis after inflammatory medical therapy. A pilot study. Circulation 2011;124:1830-7.
43. Baccouche H, Mahrholdt H, Meinhardt G, et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J 2009;30:2869-79.